C105H137N41O16S — CID 157099716
5-acetamido-N-(3-acetyl-1-methylpyrazol-5-yl)-1-methylpyrazole-3-carboxamide;5-acetamido-4-(1,3-benzothiazol-2-yl)-1-(4-methylphenyl)-N-phenylpyrazole-3-carboxamide;5-acetamido-N-(2,5-dimethylpyrazol-3-yl)-1-methylpyrazole-3-carboxamide;3-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-5-carboxamide;5-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-3-carboxamide;3-[[5-[3-(dimethylamino)propanoylamino]-1-methylpyrazole-3-carbonyl]amino]-1-methyl-N-propylpyrazole-5-carboxamide (PubChem CID 157099716) has the molecular formula C105H137N41O16S and a molecular weight of 2261.59 g/mol. Its IUPAC name is 5-acetamido-N-(3-acetyl-1-methylpyrazol-5-yl)-1-methylpyrazole-3-carboxamide;5-acetamido-4-(1,3-benzothiazol-2-yl)-1-(4-methylphenyl)-N-phenylpyrazole-3-carboxamide;5-acetamido-N-(2,5-dimethylpyrazol-3-yl)-1-methylpyrazole-3-carboxamide;3-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-5-carboxamide;5-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-3-carboxamide;3-[[5-[3-(dimethylamino)propanoylamino]-1-methylpyrazole-3-carbonyl]amino]-1-methyl-N-propylpyrazole-5-carboxamide.
| Compound Name | 5-acetamido-N-(3-acetyl-1-methylpyrazol-5-yl)-1-methylpyrazole-3-carboxamide;5-acetamido-4-(1,3-benzothiazol-2-yl)-1-(4-methylphenyl)-N-phenylpyrazole-3-carboxamide;5-acetamido-N-(2,5-dimethylpyrazol-3-yl)-1-methylpyrazole-3-carboxamide;3-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-5-carboxamide;5-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-3-carboxamide;3-[[5-[3-(dimethylamino)propanoylamino]-1-methylpyrazole-3-carbonyl]amino]-1-methyl-N-propylpyrazole-5-carboxamide |
|---|---|
| PubChem CID | 157099716 |
| Molecular Formula | C105H137N41O16S |
| Molecular Weight | 2261.59 g/mol |
| Exact Mass | 2260.09 |
| IUPAC Name | 5-acetamido-N-(3-acetyl-1-methylpyrazol-5-yl)-1-methylpyrazole-3-carboxamide;5-acetamido-4-(1,3-benzothiazol-2-yl)-1-(4-methylphenyl)-N-phenylpyrazole-3-carboxamide;5-acetamido-N-(2,5-dimethylpyrazol-3-yl)-1-methylpyrazole-3-carboxamide;3-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-5-carboxamide;5-[3-(dimethylamino)propanoylamino]-1-methyl-N-[1-methyl-3-(propylcarbamoyl)pyrazol-5-yl]pyrazole-3-carboxamide;3-[[5-[3-(dimethylamino)propanoylamino]-1-methylpyrazole-3-carbonyl]amino]-1-methyl-N-propylpyrazole-5-carboxamide |
| SMILES | CC(=O)Nc1c(-c2nc3ccccc3s2)c(C(=O)Nc2ccccc2)nn1-c1ccc(C)cc1.CC(=O)Nc1cc(C(=O)Nc2cc(C(C)=O)nn2C)nn1C.CC(=O)Nc1cc(C(=O)Nc2cc(C)nn2C)nn1C.CCCNC(=O)c1cc(NC(=O)c2cc(NC(=O)CCN(C)C)n(C)n2)n(C)n1.CCCNC(=O)c1cc(NC(=O)c2cc(NC(=O)CCN(C)C)n(C)n2)nn1C.CCCNC(=O)c1cc(NC(=O)c2cc(NC(=O)CCN(C)C)nn2C)n(C)n1 |
| InChI | InChI=1S/C26H21N5O2S.3C18H28N8O3.C13H16N6O3.C12H16N6O2/c1-16-12-14-19(15-13-16)31-24(27-17(2)32)22(26-29-20-10-6-7-11-21(20)34-26)23(30-31)25(33)28-18-8-4-3-5-9-18;1-6-8-19-18(29)13-11-14(23-25(13)4)20-17(28)12-10-15(26(5)22-12)21-16(27)7-9-24(2)3;1-6-8-19-17(28)12-10-15(26(5)22-12)21-18(29)13-11-14(23-25(13)4)20-16(27)7-9-24(2)3;1-6-8-19-17(28)12-10-15(26(5)22-12)21-18(29)13-11-14(25(4)23-13)20-16(27)7-9-24(2)3;1-7(20)9-5-12(19(4)16-9)15-13(22)10-6-11(14-8(2)21)18(3)17-10;1-7-5-10(17(3)15-7)14-12(20)9-6-11(13-8(2)19)18(4)16-9/h3-15H,1-2H3,(H,27,32)(H,28,33);10-11H,6-9H2,1-5H3,(H,19,29)(H,21,27)(H,20,23,28);10-11H,6-9H2,1-5H3,(H,19,28)(H,21,29)(H,20,23,27);10-11H,6-9H2,1-5H3,(H,19,28)(H,20,27)(H,21,29);5-6H,1-4H3,(H,14,21)(H,15,22);5-6H,1-4H3,(H,13,19)(H,14,20) |
| InChIKey | AFPWURVYHIDZNX-UHFFFAOYSA-N |
| XLogP | 8.22 |
| TPSA | 672.20 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 163 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2261.59 |
| LogP ≤ 5 | 8.22 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 43 |